Related Experiment Video
Updated: Aug 21, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Malignancy arising in residual endometriosis following hysterectomy and hormone replacement therapy
Nadia F Soliman1, A Jeremy Evans
1Obstetrics and Gynaecology, The Royal Bournemouth Hospital, Bournemouth, UK.
Abstract:
Two women with adenocarcinoma of the endometrium and a past history of disseminated pelvic endometriosis presented with vaginal bleeding. One also had obstructive uropathy. The two patients had undergone total abdominal hysterectomy with removal of one or both ovaries three and 13 years previously and subsequently were treated with unopposed oestrogen replacement therapy. Adenocarcinoma of the endometrium following endometriosis is a rare condition and few cases are reported in the literature. A summary of the cases and related literature are presented.
